Cellebrite Thomas Hogan Sells 103K Shares: Investor Outlook
Cellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
Understand the criteria that trigger Enhanced Due Diligence in crypto platforms, including transaction patterns and risk indicators.
13,796 articlesCellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
End your week with clarity. This Friday reads roundup translates market happenings into actionable ideas for your por...
Online spa searches can lead to glossy listings that look legit—until deposits are requested and real businesses deny...
Learn a practical plan to grow a multi-zone rental portfolio without traveling. This guide covers financing strategie...
Looking for biotech growth with real upside? This piece breaks down two innovative biotech stocks that could deliver ...
Small, nearly unknown biotech stocks can surge when their pipeline milestones hit. This guide breaks down how to spot...
Investors can buy stakes in the first Atari Hotel Phoenix via a Regulation A+ offering, marking a bold move by the ic...
A leading hedge fund just disclosed a sizable new stake in Disc Medicine. This article breaks down what Disc Medicine...
Netflix’s strategic shift sent a ripple through the market, highlighting how breakup fees and deal terms shape stream...
A sudden price jump can grab headlines and wallets. This guide explains why stock soared today, how to verify the dri...
A new ATTOM report shows rental yields are falling in the majority of U.S. counties as high home prices squeeze inves...
A senior executive recently reduced his stake in CATY by one third through an open market sale. This article explains...